DK134599B - Analogifremgangsmåde til fremstilling af pyrroleddikesyrederivater og salte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af pyrroleddikesyrederivater og salte deraf.Info
- Publication number
- DK134599B DK134599B DK638372AA DK638372A DK134599B DK 134599 B DK134599 B DK 134599B DK 638372A A DK638372A A DK 638372AA DK 638372 A DK638372 A DK 638372A DK 134599 B DK134599 B DK 134599B
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- preparation
- acid derivatives
- analogous process
- pyrroleacetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE777207A BE777207A (en) | 1971-12-23 | 1971-12-23 | 3-pyrroleacetic acids - analgesics, antipyretics antiinflammatories prepd by hydrolysis of the corresp acid deriv |
| BE785274A BE785274R (en) | 1972-06-22 | 1972-06-22 | Pyrrole-3-acetic acids - useful as antiinflammatory analgesic and anti pyretic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK134599B true DK134599B (da) | 1976-12-06 |
| DK134599C DK134599C (da) | 1977-05-09 |
Family
ID=25656964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK638372AA DK134599B (da) | 1971-12-23 | 1972-12-21 | Analogifremgangsmåde til fremstilling af pyrroleddikesyrederivater og salte deraf. |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5318507B2 (da) |
| AR (1) | AR208494A1 (da) |
| AT (1) | AT323727B (da) |
| AU (1) | AU467602B2 (da) |
| CA (1) | CA991193A (da) |
| CH (1) | CH563364A5 (da) |
| DD (1) | DD104976A5 (da) |
| DE (1) | DE2261965A1 (da) |
| DK (1) | DK134599B (da) |
| ES (1) | ES409944A1 (da) |
| FR (1) | FR2164857B1 (da) |
| GB (1) | GB1406330A (da) |
| HU (1) | HU165900B (da) |
| IE (1) | IE37237B1 (da) |
| IL (1) | IL41146A (da) |
| NL (1) | NL7217521A (da) |
| OA (1) | OA04523A (da) |
| PL (1) | PL89071B1 (da) |
| SE (1) | SE388853B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2645234A1 (de) * | 1976-10-07 | 1978-04-20 | Basf Ag | 2,5-dialkoxy-3-amino-methyltetrahydrofurane und verfahren zu ihrer herstellung |
| US4248784A (en) * | 1977-02-25 | 1981-02-03 | Sterling Drug Inc. | Pyrrole-3-acetamides |
| DE3026402A1 (de) * | 1980-07-11 | 1982-02-04 | Syntex Corp., Palo Alto, Calif. | Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen |
| US4973704A (en) * | 1985-10-25 | 1990-11-27 | Sandoz Pharm. Corp. | Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof |
| US4851427A (en) * | 1985-10-25 | 1989-07-25 | Sandoz Pharm. Corp. | Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use |
| KR900001212B1 (ko) * | 1985-10-25 | 1990-02-28 | 산도즈 파마슈티칼스 코오포레이숀 | 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도 |
| US5260451A (en) * | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
| DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
| US5935990A (en) * | 1996-12-10 | 1999-08-10 | G.D. Searle & Co. | Substituted pyrrolyl compounds for the treatment of inflammation |
| ES2555511T3 (es) * | 2006-08-03 | 2016-01-04 | Rottapharm Biotech S.R.L. | Inhibidores de COX-2 altamente selectivos y eficaces por vía oral de 1,5-diaril-2-alquil-pirroles 3-sustituidos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1228301A (da) * | 1968-04-16 | 1971-04-15 |
-
1972
- 1972-12-18 DE DE19722261965 patent/DE2261965A1/de active Pending
- 1972-12-20 HU HUCO272A patent/HU165900B/hu unknown
- 1972-12-20 GB GB5877272A patent/GB1406330A/en not_active Expired
- 1972-12-20 AU AU50338/72A patent/AU467602B2/en not_active Expired
- 1972-12-21 AR AR245771A patent/AR208494A1/es active
- 1972-12-21 AT AT1093772A patent/AT323727B/de not_active IP Right Cessation
- 1972-12-21 SE SE7216774A patent/SE388853B/xx unknown
- 1972-12-21 DK DK638372AA patent/DK134599B/da unknown
- 1972-12-21 IE IE1781/72A patent/IE37237B1/xx unknown
- 1972-12-21 PL PL1972159744A patent/PL89071B1/pl unknown
- 1972-12-22 CA CA159,778A patent/CA991193A/en not_active Expired
- 1972-12-22 ES ES409944A patent/ES409944A1/es not_active Expired
- 1972-12-22 FR FR7245868A patent/FR2164857B1/fr not_active Expired
- 1972-12-22 DD DD168267*A patent/DD104976A5/xx unknown
- 1972-12-22 NL NL7217521A patent/NL7217521A/xx unknown
- 1972-12-22 IL IL41146A patent/IL41146A/en unknown
- 1972-12-22 CH CH1882972A patent/CH563364A5/fr not_active IP Right Cessation
- 1972-12-23 OA OA54792A patent/OA04523A/xx unknown
- 1972-12-23 JP JP404973A patent/JPS5318507B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AR208494A1 (es) | 1977-02-15 |
| JPS5318507B2 (da) | 1978-06-15 |
| JPS4868562A (da) | 1973-09-18 |
| ES409944A1 (es) | 1976-03-16 |
| AU5033872A (en) | 1974-06-20 |
| SE388853B (sv) | 1976-10-18 |
| DK134599C (da) | 1977-05-09 |
| CH563364A5 (da) | 1975-06-30 |
| DD104976A5 (da) | 1974-04-05 |
| IE37237L (en) | 1973-06-23 |
| AT323727B (de) | 1975-07-25 |
| CA991193A (en) | 1976-06-15 |
| NL7217521A (da) | 1973-06-26 |
| FR2164857B1 (da) | 1976-03-05 |
| DE2261965A1 (de) | 1973-06-28 |
| PL89071B1 (en) | 1976-10-30 |
| FR2164857A1 (da) | 1973-08-03 |
| HU165900B (da) | 1974-12-28 |
| GB1406330A (en) | 1975-09-17 |
| AU467602B2 (en) | 1974-06-20 |
| OA04523A (fr) | 1980-03-30 |
| IE37237B1 (en) | 1977-06-08 |
| IL41146A (en) | 1977-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK139869B (da) | Analogifremgangsmåde til fremstilling af phenyl-imidazolyl-alkansyrederivater eller salte deraf. | |
| DK136981B (da) | Analogifremgangsmåde til fremstilling af basisk substituerede benzylphthalazon-derivater. | |
| DK136157B (da) | Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf. | |
| DK127106B (da) | Analogifremgangsmåde til fremstilling af basiske aryloxy-acetamider og syreadditionssalte deraf. | |
| DK134599B (da) | Analogifremgangsmåde til fremstilling af pyrroleddikesyrederivater og salte deraf. | |
| DK140545B (da) | Analogifremgangsmåde til fremstilling af benzoylphenylsmørsyrederivater eller salte deraf. | |
| DK130212B (da) | Analogifremgangsmåde til fremstilling af 7-aminoindazolderivater. | |
| DK131778B (da) | Fremgangsmåde til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf. | |
| DK140986B (da) | Analogifremgangsmåde til fremstilling af 8-substituerede D-2-halogen-6-methyl-ergoliner og salte heraf. | |
| DK138744B (da) | Analogifremgangsmåde til fremstilling af terapeutisk anvendelige isoquinolinderivater eller salte deraf. | |
| DK140669B (da) | Fremgangsmåde til fremstilling af alfa-aminobenzylpenicilliner og salte heraf. | |
| DK134485B (da) | Analogifremgangsmåde til fremstilling af thiocarbaminsyrederivater. | |
| DK131857B (da) | Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf. | |
| DK132504B (da) | Fremgangsmåde til fremstilling af et antibiotisk kompleks kaldet Bu-1975, komponenter C1 og C2 deraf og syreadditionssalte heraf. | |
| DK133667B (da) | Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater. | |
| DK129240B (da) | Analogifremgangsmåde til fremstilling af 1-imidazolyl-methanphosphonsyreestere eller salte deraf. | |
| DK125137B (da) | Analogifremgangsmåde til fremstilling af phenthiazinderivater og oximer og syreadditionssalte deraf. | |
| DK138490B (da) | Fremgangsmåde til fremstilling af prostadiensyrederivater. | |
| DK133464B (da) | Analogifremgangsmåde til fremstilling af nitrosourinstofderivater. | |
| DK134154B (da) | Analogifremgangsmåde til fremstilling af 5-cyklohexyl-1-indankarboxylsyrederivater. | |
| DK136906B (da) | Analogifremgangsmåde til fremstilling af dibenzoxyrenazepinderivater eller salte deraf. | |
| DK137192B (da) | Analogifremgangsmåde til fremstilling af cephalosporansyrederivater. | |
| DK133622B (da) | Fremgangsmåde til fremstilling af antibiotikum A28695A eller A28695B eller salte heraf. | |
| DK129237B (da) | Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater og salte deraf. | |
| DK138450B (da) | Fremgangsmåde til fremstilling af arylamino-2-imidazoliner og syreadditionssalte deraf. |